These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha. Niessner A; Sato K; Chaikof EL; Colmegna I; Goronzy JJ; Weyand CM Circulation; 2006 Dec; 114(23):2482-9. PubMed ID: 17116765 [TBL] [Abstract][Full Text] [Related]
44. Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis. Shimada K Circ J; 2009 Jun; 73(6):994-1001. PubMed ID: 19430164 [TBL] [Abstract][Full Text] [Related]
45. p-Coumaric acid inhibits indoleamine 2, 3-dioxygenase expression in murine dendritic cells. Kim SI; Jeong YI; Jung ID; Lee JS; Lee CM; Yoon MS; Seong EY; Kim JI; Lee JD; Park YM Int Immunopharmacol; 2007 Jun; 7(6):805-15. PubMed ID: 17466914 [TBL] [Abstract][Full Text] [Related]
46. Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G. Tay C; Liu YH; Kanellakis P; Kallies A; Li Y; Cao A; Hosseini H; Tipping P; Toh BH; Bobik A; Kyaw T Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e71-e84. PubMed ID: 29599140 [TBL] [Abstract][Full Text] [Related]
47. MCS-18, a natural product isolated from Helleborus purpurascens, inhibits maturation of dendritic cells in ApoE-deficient mice and prevents early atherosclerosis progression. Dietel B; Muench R; Kuehn C; Kerek F; Steinkasserer A; Achenbach S; Garlichs CD; Zinser E Atherosclerosis; 2014 Aug; 235(2):263-72. PubMed ID: 24887015 [TBL] [Abstract][Full Text] [Related]
48. The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. Chen W; Liang X; Peterson AJ; Munn DH; Blazar BR J Immunol; 2008 Oct; 181(8):5396-404. PubMed ID: 18832696 [TBL] [Abstract][Full Text] [Related]
49. Deficiency of invariant V alpha 14 natural killer T cells decreases atherosclerosis in LDL receptor null mice. Rogers L; Burchat S; Gage J; Hasu M; Thabet M; Willcox L; Ramsamy TA; Whitman SC Cardiovasc Res; 2008 Apr; 78(1):167-74. PubMed ID: 18192239 [TBL] [Abstract][Full Text] [Related]
54. Apoptotic cells induce dendritic cell-mediated suppression via interferon-gamma-induced IDO. Williams CA; Harry RA; McLeod JD Immunology; 2008 May; 124(1):89-101. PubMed ID: 18067553 [TBL] [Abstract][Full Text] [Related]
55. Sphingosine kinase inhibition exerts both pro- and anti-atherogenic effects in low-density lipoprotein receptor-deficient (LDL-R(-/-)) mice. Poti F; Bot M; Costa S; Bergonzini V; Maines L; Varga G; Freise H; Robenek H; Simoni M; Nofer JR Thromb Haemost; 2012 Mar; 107(3):552-61. PubMed ID: 22234485 [TBL] [Abstract][Full Text] [Related]
56. Inhibitory oligodeoxynucleotides downregulate herpes simplex virus-induced plasmacytoid dendritic cell type I interferon production and modulate cell function. Peng WM; Yu CF; Allam JP; Oldenburg J; Bieber T; Hoch J; Eis-Hübinger AM; Novak N Hum Immunol; 2007 Nov; 68(11):879-87. PubMed ID: 18082566 [TBL] [Abstract][Full Text] [Related]
57. Myeloid interferon-γ receptor deficiency does not affect atherosclerosis in LDLR(-/-) mice. Boshuizen MC; Neele AE; Gijbels MJ; van der Velden S; Hoeksema MA; Forman RA; Muller W; Van den Bossche J; de Winther MP Atherosclerosis; 2016 Mar; 246():325-33. PubMed ID: 26828750 [TBL] [Abstract][Full Text] [Related]
58. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Meurs I; Lammers B; Zhao Y; Out R; Hildebrand RB; Hoekstra M; Van Berkel TJ; Van Eck M Atherosclerosis; 2012 Mar; 221(1):41-7. PubMed ID: 22196936 [TBL] [Abstract][Full Text] [Related]